In early 2022, four new grants were awarded to advance research in FA cancer preclinical models, Fanconi Anemia Neurological Syndrome (FANS), and mental health.
FARF friend and board member Sharon Schuman held her annual concert and wine benefit for FA research on April 8 in Eugene, Ore. FARF co-founder Lynn Frohnmayer spoke about the future of FA research.
Despite a rare, incurable disease, Amy Frohnmayer Winn ran joyfully through her limited time on earth, making the most of every mile—and every moment.
The daughter of the late University of Oregon President Dave Frohnmayer and his wife Lynn was one of their 3 daughters who inherited Fanconi Anemia, which can lead to bone marrow failure and cancer.